186 related articles for article (PubMed ID: 28153452)
21. Methotrexate effects on adenosine receptor expression in peripheral monocytes of persons with type 2 diabetes and cardiovascular disease.
Reiss AB; Teboul I; Kasselman L; Ahmed S; Carsons SE; De Leon J
J Investig Med; 2022 Aug; 70(6):1433-1437. PubMed ID: 35606100
[TBL] [Abstract][Full Text] [Related]
22. Use of knockout mice to explore CNS effects of adenosine.
Lopes CR; Lourenço VS; Tomé ÂR; Cunha RA; Canas PM
Biochem Pharmacol; 2021 May; 187():114367. PubMed ID: 33333075
[TBL] [Abstract][Full Text] [Related]
23. Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation.
Borroto-Escuela DO; Hinz S; Navarro G; Franco R; Müller CE; Fuxe K
Front Neurosci; 2018; 12():43. PubMed ID: 29467608
[TBL] [Abstract][Full Text] [Related]
24. The Adenosinergic System in Diabetic Retinopathy.
Vindeirinho J; Santiago AR; Cavadas C; Ambrósio AF; Santos PF
J Diabetes Res; 2016; 2016():4270301. PubMed ID: 27034960
[TBL] [Abstract][Full Text] [Related]
25. The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells.
Bshesh K; Zhao B; Spight D; Biaggioni I; Feokistov I; Denenberg A; Wong HR; Shanley TP
J Leukoc Biol; 2002 Nov; 72(5):1027-36. PubMed ID: 12429726
[TBL] [Abstract][Full Text] [Related]
26. A Novel Method for Screening Adenosine Receptor Specific Agonists for Use in Adenosine Drug Development.
Jones KR; Choi U; Gao JL; Thompson RD; Rodman LE; Malech HL; Kang EM
Sci Rep; 2017 Mar; 7():44816. PubMed ID: 28317879
[TBL] [Abstract][Full Text] [Related]
27. Regulation of atherosclerosis and associated risk factors by adenosine and adenosine receptors.
Koupenova M; Johnston-Cox H; Ravid K
Curr Atheroscler Rep; 2012 Oct; 14(5):460-8. PubMed ID: 22850979
[TBL] [Abstract][Full Text] [Related]
28. Modulation of innate immunity by adenosine receptor stimulation.
Ramakers BP; Riksen NP; van der Hoeven JG; Smits P; Pickkers P
Shock; 2011 Sep; 36(3):208-15. PubMed ID: 21617576
[TBL] [Abstract][Full Text] [Related]
29. Expression and Impact of Adenosine A
Tarifa C; Jiménez-Sábado V; Franco R; Montiel J; Guerra J; Ciruela F; Hove-Madsen L
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901835
[TBL] [Abstract][Full Text] [Related]
30. Theobromine-Induced Changes in A1 Purinergic Receptor Gene Expression and Distribution in a Rat Brain Alzheimer's Disease Model.
Mendiola-Precoma J; Padilla K; Rodríguez-Cruz A; Berumen LC; Miledi R; García-Alcocer G
J Alzheimers Dis; 2017; 55(3):1273-1283. PubMed ID: 27792010
[TBL] [Abstract][Full Text] [Related]
31. Targeting purinergic receptors to attenuate inflammation of dry eye.
Wang JN; Fan H; Song JT
Purinergic Signal; 2023 Mar; 19(1):199-206. PubMed ID: 35218451
[TBL] [Abstract][Full Text] [Related]
32. Adenosine A2A receptor is involved in cell surface expression of A2B receptor.
Moriyama K; Sitkovsky MV
J Biol Chem; 2010 Dec; 285(50):39271-88. PubMed ID: 20926384
[TBL] [Abstract][Full Text] [Related]
33. Adenosine, Adenosine Receptors and Neurohumoral Syncope: From Molecular Basis to Personalized Treatment.
Guieu R; Degioanni C; Fromonot J; De Maria L; Ruf J; Deharo JC; Brignole M
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625864
[TBL] [Abstract][Full Text] [Related]
34. [Effect of Electroacupuncture on Adenosine Receptor Expression in White Adipose Tissue of Diet-induced Obese Mice].
Tang YX; Meng JZ; Ding YJ; Hong H; Yu ML; Jing XY; Lu SF; Zhu BM
Zhen Ci Yan Jiu; 2017 Feb; 42(1):39-44. PubMed ID: 29071996
[TBL] [Abstract][Full Text] [Related]
35. Adenosine and preeclampsia.
Salsoso R; Farías M; Gutiérrez J; Pardo F; Chiarello DI; Toledo F; Leiva A; Mate A; Vázquez CM; Sobrevia L
Mol Aspects Med; 2017 Jun; 55():126-139. PubMed ID: 28089907
[TBL] [Abstract][Full Text] [Related]
36. Adenosine A
Skopál A; Ujlaki G; Gerencsér AT; Bankó C; Bacsó Z; Ciruela F; Virág L; Haskó G; Kókai E
Curr Issues Mol Biol; 2023 Jun; 45(6):4948-4969. PubMed ID: 37367064
[TBL] [Abstract][Full Text] [Related]
37. Adenosine receptors as potential targets in melanoma.
Montinaro A; Iannone R; Pinto A; Morello S
Pharmacol Res; 2013 Oct; 76():34-40. PubMed ID: 23856527
[TBL] [Abstract][Full Text] [Related]
38. Biased agonism at adenosine receptors.
McNeill SM; Baltos JA; White PJ; May LT
Cell Signal; 2021 Jun; 82():109954. PubMed ID: 33610717
[TBL] [Abstract][Full Text] [Related]
39. Long-term consequences of disrupting adenosine signaling during embryonic development.
Rivkees SA; Wendler CC
Mol Aspects Med; 2017 Jun; 55():110-117. PubMed ID: 28202385
[TBL] [Abstract][Full Text] [Related]
40. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
